Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Raghunandan Vikram Image

      Raghunandan Vikram, M.B.B.S., M.R.C.P., F.R.C.R., M.B.A.

      Department of Abdominal Imaging, Division of Diagnostic Imaging

      About Dr. Vikram

      Dr. Vikram is a Professor of Radiology in Abdominal Imaging. He obtained his medical degree from Jawaharlal Nehru Medical College, Belgaum, India. He completed residency training in internal medicine before his radiology training in the United Kingdom and is board certified in both medicine and radiology in the United Kingdom. He is also board certified by the American Board of Radiology. Dr. Vikram completed his fellowship in abdominal radiology at The University of Texas MD Anderson Cancer Center in 2006-2007 and has been a faculty since. He currently serves as the Fellowship Director for Body Imaging Fellowship at The University of MD Anderson Cancer Center.

      Dr. Vikram has published more than 71 peer-reviewed articles, 4 book chapters, and more than 75 abstracts. Dr. Vikram serves as a journal reviewer for several scientific journals including JMRI and Abdominal Imaging. He serves on expert panels in the American College of Radiology Appropriateness criteria for Genitourinary Radiology and in the American Joint Committee for Cancer. He serves in various leadership positions and several national radiology societies including the Radiological Society of North America and Society of Abdominal Imaging. Dr. Vikram has lectured extensively at a national and international level and was awarded the RSNA Honored Education Award in 2012. Dr. Vikram’s areas of interest include imaging of abdominal and pelvic malignancies with special emphasis on genito-urinary malignancies, and identification of imaging surrogates of genetic aberrations in malignancies.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      Genitourinary Imaging, PETCT, MRI

      Clinical Interests

      Genitourinary

      Education & Training

      Degree-Granting Education

      2020Kellogg School of Management, Northwestern University, Evanston, Illinois, US, Business Administration, MBA
      1997Jawaharlal Nehru Medical College, Belgaum, IN, Medicine, MBBS

      Postgraduate Training

      2017-2017American Board of Medical Quality, Certification, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2014-2015Graduate Certificate in Healthcare Administration, Rice University, Houston, Texas
      2011-2012Heart of Leadership, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2006-2007Clinical Fellowship, Body Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2001-2006Clinical Residency, Clinical Radiology, East Scotland Training Scheme, Edinburgh and Dundee
      1998-2001Clinical Residency, Internal Medicine, National Health Service Hospitals, Carmarthen and Birmingham
      1997-1997Clinical Residency, Cardiology, Sri Jayadeva Institute of Cardiology, Bangalore
      1996-1997Clinical Internship, Medicine and Surgery, Jawaharlal Nehru Medical College Hospital, Belgaum

      Licenses & Certifications

      2010American Board of Radiology
      2007Texas Medical Board
      2004Royal College of Radiology
      2001General Medical Council
      2001Royal College of Physicians
      1997Karnataka Medical Council

      Experience & Service

      Faculty Academic Appointments

      Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019

      Associate Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2017

      Assistant Professor, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2012

      Administrative Appointments/Responsibilities

      Director of Advanced Practice Providers, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019

      Co-Section Chief, ad interim, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2018

      Fellowship Director, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022

      EHR Provider Officer, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018

      Other Professional Positions

      Consultant, Global Business Development Office - The University of Texas MD Anderson Cancer Center, Houston, Texas, 2015 - Present

      Extramural Institutional Committee Activities

      Member, Diagnostic Imaging Promotion and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Member, Diagnostic Imaging Functional Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018

      Member, Diagnostic Radiology Executive Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2018

      Member, Diagnostic Radiology Faculty Merit Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Member, Diagnostic Imaging Education Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

      Member, DI Informatics Functional Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2019

      Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2012 - 2015

      Member, Body Imaging Quality Improvement Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2012

      Member, Body Imaging Computed Tomography Protocol Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Editorial Activities

      Board Member, World Journal of Radiology, 2009 - 2011

      Honors & Awards

      2016Diagnostic Radiology Enhancement Award, The University of Texas MD Anderson Cancer Center
      2016President's Recognition of Faculty Excellence, The University of Texas MD Anderson Cancer Center
      2012RSNA Honored Educator Award, Radiological Society of North America
      2011Certificate of Merit for Education Exhibits, Management and follow-up guidelines of pancreatic cystic lesions: current update for radiologists, 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2011Certificate of Merit for Education Exhibits, Topographical localization of solid renal masses in adults: a systematic review, 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2010Certificate of Merit for Education Exhibits, Benign scrotal tumors and pseudo tumors: imaging diagnosis and pathological correlation, 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2010Certificate of Merit for Education Exhibits, Rare (<1%) histological subtypes of renal cell carcinoma: a comprehensive review, 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2010Certificate of Merit for Education Exhibits, Lymph node imaging: current concepts and future perspectives, 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2009Certificate of Merit with Excellence in Design for Education Exhibit, Pathways of extra-pelvic spread of disease: imaging findings, 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2009Certificate of Merit for Education Exhibit, Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation, 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2009Certificate of Merit for Education Exhibit, Spectrum of medication-induced complications in the belly: role of cross sectional imaging, and implications on management, 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2007Cum Laude for Education Exhibit, Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease, 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America
      2003 - 2004Amersham Scholarship, Scottish Radiological Society
      2003Pfizer Prize, Junior Doctors' Scientific Forum, Ninewells Hospital and Medical School - Dundee, Scotland
      1993 - 1994Certificate of Merit, Jawaharlal Nehru Medical College - Belgaum, India
      1991Certificate of Merit, Pre-University Board - Karnataka, India
      1989National Merit Scholar, National Merit Scholarship

      Professional Memberships

      American Society of Clinical Oncology

      2017 - Present

      American Board of Radiology

      2017 - Present

      SIU-ICUD International Consultation on Urologic Diseases

      2017 - Present

      The American Joint Committee on Cancer

      2015 - Present

      Society of Abdominal Radiology

      2013 - Present

      American College of Radiology

      2010 - Present

      Texas Medical Association

      2007 - Present

      Harris County Medical Society

      2007 - Present

      Society of Uroradiology

      2007 - 2013

      European Society of Radiology

      2007 - Present

      Royal College of Radiologists

      2004 - Present

      American Roentgen Ray Society

      2004 - 2013

      Radiological Society of North America

      2003 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2018. Treatment response/recurrence, radiologic technologist sessions. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      2. 2018. F-18 FDG colorectal cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      3. 2018. Renal cell carcinoma: treatment response/recurrence, abdomen and pelvis subspecialty track. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      4. 2010. Ultrasound in deep vein thrombosis. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      5. 2009. Ultrasound in DVT, division of diagnostic imaging quality improvement noon conference. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      6. 2009. Deep vein thrombosis in the cancer patient. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      7. 2008. Long term risks from radiological screening tests. what do we know?. Conference. VHL Family Alliance. Houston, TX, US.

      National Presentations

      1. 2024. Mucinous rectal adenocarcinoma-unique imaging features. Invited. Society of Abdominal Radiology Annual Meeting. Hollywood, FL, US.
      2. 2023. Mucinous rectal adenocarcinoma-challenges in image interpretation (Workshop). Invited. Society of Abdominal Radiology Annual Meeting. Austin, TX, US.
      3. 2022. Role of FDG PET-CT in pancreatic ductal adenocarcinoma (Workshop). Invited. Society of Abdominal Radiology Annual Meeting. Scottsdale, AZ, US.
      4. 2022. High resolution MRI cancer of the penis and urethra (Workshop). Invited. Society of Abdominal Radiology Annual Meeting. Scottsdale, AZ, US.
      5. 2019. Penile and male urethral tumors. Invited. American Roentgen Ray Society 119th Annual Meeting. Honolulu, HI, US.
      6. 2019. Imaging in characterization and preoperative planning of renal masses. Invited. Society of Abdominal Radiology. Orlando, FL, US.
      7. 2019. MRI of penile cancer - how do I do it. Invited. Society of Abdominal Radiology. Orlando, FL, US.
      8. 2017. Renal cell carcinoma: how imaging can be used to select among treatment options and monitor response. Invited. 103rd Scientific Assembly and Annual Meeting of The Radiological Society of North America. Chicago, IL, US.
      9. 2017. A tale of two tumors: current update in genetics and imaging of pheochromocytomas and paragangliomas. Conference. 103rd Scientific Assembly and Annual Meeting of The Radiological Society of North America. Chicago, IL, US.
      10. 2017. High resolution MRI cancer of the penis and urethra. Invited. Society of Abdominal Radiology. Hollywood, FL, US.
      11. 2016. Renal cell carcinoma: how imaging can be used to select among treatment options and monitor response. Invited. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      12. 2016. Genitourinary (evaluation of renal masses): differentiation of papillary type 1 and type 2 RCC on CT textural analysis. Invited. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      13. 2016. All in the family: current update on genetics and imaging of hereditary renal cell carcinomas. Conference. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      14. 2015. Challenges and solution of inter observer variability in the interpretation of high resolution MRI in staging of primary rectal cancer. Conference. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      15. 2015. Added value of FDG-PET/CT in detecting non-peritoneal metastases in patients with gastric carcinoma. Conference. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      16. 2015. Interobserver variability in interpretation of high resolution MRI of primary rectal cancer. Conference. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      17. 2015. Cross-sectional imaging spectrum of extra-pulmonary inflammatory myofibroblastic tumors. Conference. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      18. 2015. Renal cell carcinoma: how imaging can be used to select among treatment options and monitor response. Invited. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      19. 2015. Cross sectional imaging spectrum of plasma cell dyscrasias. Conference. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Meeting Program. Chicago, IL, US.
      20. 2015. The CT urogram: technique applications and findings. Invited. 10th Oncologic Imaging: A Multidisciplinary Approach. Asheville, NC, US.
      21. 2015. Cystic tumors of the pancreas. Invited. 10th Oncologic Imaging: A Multidisciplinary Approach. Asheville, NC, US.
      22. 2015. Imaging primary renal cell cancer. Invited. 10th Oncologic Imaging: A Multidisciplinary Approach. Asheville, NC, US.
      23. 2015. MRI in rectal carcinoma: why, what, when & how. Invited. Texas Radiological Society 102nd Annual Scientific Meeting & Exhibit Program. Austin, TX, US.
      24. 2015. High resolution MRI cancer of the penis and urethra. Invited. Society of Abdominal Radiology. San Diego, CA, US.
      25. 2014. Can cytopathology, radiology and molecular markers put together the pieces of the adrenal mass puzzle?. Invited. 62nd Annual Scientific Meeting of the American Society of Cytopathology. Dallas, TX, US.
      26. 2014. High resolution MRI cancer of the penis and urethra. Invited. Society of Abdominal Radiology. Boca Raton, FL, US.
      27. 2014. Tumefactive fibro-inflammatory disorders of the abdomen and pelvis: 2014 update. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      28. 2014. Tapping into big data in images: annotation and image markup, tools, and applications (Hands-on). Invited. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      29. 2014. State-of-the-art cross sectional imaging of lymph nodes in common genitourinary malignancies: a current comprehensive update. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      30. 2014. Tubulocystic renal cell carcinoma: a new recognized epithelial tumor. Conference. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      31. 2013. Abdominal oncologic applications of dual energy CT (DECT): where do we stand?. Conference. 99th Annual Scientific Assembly and Annual Meeting of the Radiology Society of North America. Chicago, IL, US.
      32. 2013. Cross-sectional imaging spectrum of hepatic angiomyolipomas. Conference. 99th Annual Scientific Assembly and Annual Meeting of the Radiology Society of North America. Chicago, IL, US.
      33. 2013. Cystic nephroma and mixed epithelial and stromal tumor of the kidney: a single clinical entity?. Conference. 99th Annual Scientific Assembly and Annual Meeting of the Radiology Society of North America. Chicago, IL, US.
      34. 2013. Image features derived from contrast enhanced CT can predict BAP1 loss in patients with clear cell renal carcinoma: results of a feasibility study. Conference. 99th Annual Scientific Assembly and Annual Meeting of the Radiology Society of North America. Chicago, IL, US.
      35. 2013. Image texture analysis on primary tumor can stratify differences in overall survival, distant metastases, tumor stage, and Fuhrman Grade in patients with clear cell renal carcinoma: results of a feasibility study. Conference. 99th Annual Scientific Assembly and Annual Meeting of the Radiology Society of North America. Chicago, IL, US.
      36. 2012. Urogynecologic PET/CT: current roles and updates. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      37. 2012. The CT urogram: technique, applications and findings. Invited. 9th Oncologic Imaging: A Multidisciplinary Approach. New York, NY, US.
      38. 2012. Mucinous tubular and spindle cell carcinoma of the kidney: MDCT findings with pathological correlation. Conference. Abdominal Radiology Course. Scottsdale, AZ, US.
      39. 2012. Adrenal collision tumors and their mimics: multimodality imaging findings. Conference. Abdominal Radiology Course. Scottsdale, AZ, US.
      40. 2012. PET CT in gynecological malignancy. Invited. Abdominal Radiology Course. Scottsdale, AZ, US.
      41. 2012. Measuring response to targeted therapies in metastatic renal cell carcinoma: current concepts and future directions. Conference. Abdominal Radiology Course. Scottsdale, AZ, US.
      42. 2011. Taxonomy and management of intraductal papillary mucinous neoplasms: a 2011 update. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      43. 2011. F18-FDG PET-CT in gynecologic malignancies: evidence, pearls, and pitfalls. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      44. 2011. Topographical localization of solid renal masses in adults: a systematic review (Certificate of Merit Award). Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      45. 2011. Genetics and imaging of pheochromocytomas and extra-adrenal paragangliomas: 2011 update. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      46. 2011. Hereditary and sporadic chromophobe renal cell carcinoma: spectrum of disease and radiologic-pathologic correlation. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      47. 2011. Imaging of porta hepatitis: spectrum of disease. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      48. 2011. Management and follow-up guidelines of pancreatic cystic lesions: current update for radiologists (Certificate of Merit Award). Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      49. 2011. The role of PET in gastric cancer. Invited. Society of Nuclear Medicine Annual Meeting. San Antonio, TX, US.
      50. 2011. Spectrum of hepatocellular carcinoma in noncirrhotic liver: a contemporary epidemiological and imaging review. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      51. 2011. Inflammatory myofibroblastic tumors of the abdomen and pelvis: spectrum of cross-sectional imaging findings. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      52. 2011. Spectrum of abdominal findings in extra-osseous myeloma: cross-sectional imaging findings. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      53. 2011. Making sense of fat containing renal and perirenal lesions and pseudotumors: a cross-sectional imaging review. Conference. American Roentgen Ray Society 111th Annual Meeting. Chicago, IL, US.
      54. 2011. Neuroendocrine tumors of the genitourinary tract in adults: cross-sectional imaging findings (Poster). Conference. Abdominal Radiology Course. Carlsbad, CA, US.
      55. 2011. MDCT in differentiating pT1-2 from pT3 tumors in renal cell carcinoma (Poster). Conference. Abdominal Radiology Course. Carlsbad, CA, US.
      56. 2011. Unusual patterns of spread of prostate carcinoma (Poster). Conference. Abdominal Radiology Course. Carlsbad, CA, US.
      57. 2011. Genitourinary malignancies TNM staging update based on the 7th edition of AJCC staging manual (2010) (Poster). Conference. Abdominal Radiology Course. Carlsbad, CA, US.
      58. 2011. Pitfalls in PETCT imaging of the abdomen and pelvis (Workshop). Invited. Abdominal Radiology Course. Carlsbad, CA, US.
      59. 2010. Benign scrotal tumors and pseudo tumors: imaging diagnosis and pathological correlation (Certificate of Merit Award). Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      60. 2010. Genotype-phenotype taxonomy of hepatocellular adenomas: 2010 update (selected for RadioGraphics). Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      61. 2010. Diffusion-weighted imaging of benign hepatic lesions. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      62. 2010. Lymph node imaging: current concepts and future perspectives (Certificate of Merit Award). Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      63. 2010. Histopathogenesis and genetics of histological subtypes of epithelial ovarian cancers: current update and implications in management. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      64. 2010. Quality improvement in CT: a program for modifying/improving abdominal/pelvic CT imaging protocols while maintaining throughput in a large clinical practice. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      65. 2010. Rare (<1%) histological subtypes of renal cell carcinoma: a comprehensive review (Certificate of Merit Award). Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      66. 2010. What is the clinical significance of FDG uptake in the prostate in a patient undergoing a PET/CT?. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      67. 2010. Clear cell renal cell carcinoma: multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) appearances. Conference. 110th Annual Meeting of the American Roentgen Ray Society. San Diego, CA, US.
      68. 2010. Screening for familial pancreatic neoplasia: a prospective, multicenter blinded study of EUS, CT, and Secretin-MRCP (The NCI-Spore Lustgarten Foundation Cancer of the Pancreas CAPS 3 Study). Conference. Digestive Disease Week. New Orleans, LA, US.
      69. 2010. Recent advances in cytogenetics & molecular biology of adult hepatocellular neoplasms: implications on imaging & management (Poster). Conference. Abdominal Radiology Course. Orlando, FL, US.
      70. 2010. Clear cell renal cell carcinoma: multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) appearances (Poster). Conference. Abdominal Radiology Course. Orlando, FL, US.
      71. 2010. PET/CT in gynecological malignancies (Workshop). Invited. Abdominal Radiology Course. Orlando, FL, US.
      72. 2010. Renal cell carcinoma: diagnosis, staging and surveillance (Workshop). Invited. Abdominal Radiology Course. Orlando, FL, US.
      73. 2009. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation (Certificate of Merit Award). Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      74. 2009. "Unsung" miscellaneous tumors and pseudotumors of the ovary: cross-sectional imaging spectrum. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      75. 2009. Somatic and visceral solitary fibrous tumors in the belly: cross-sectional imaging spectrum. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      76. 2009. Spectrum of medication-induced complications in the belly: role of cross sectional imaging, and implications on management (Certificate of Merit Award). Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      77. 2009. Pathways of extra-pelvic spread of disease: imaging findings (Excellence in Design, Certificate of Merit Award). Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      78. 2009. Extramural venous invasion by gastrointestinal malignancies: CT appearances. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      79. 2009. Pathways of spread of disease to the thorax: what the abdominal radiologist needs to know. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      80. 2009. Kohler’s disease of the tarsal navicular bone: does it exist? (Scientific Paper). Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      81. 2009. Renal cell carcinoma: diagnosis, staging and surveillance. Invited. Abdominal Radiology Course. Maui, HI, US.
      82. 2009. PET/CT in management of cancers of the female reproductive tract. Invited. Abdominal Radiology Course. Maui, HI, US.
      83. 2008. Pathways of perineural and periarterial spread by pancreatic adenocarcinoma. Conference. 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      84. 2008. The value of CT scan of abdomen and pelvis in patients with treated colorectal cancer in the setting of an undetectable carcinoembryonic antigen (CEA). Conference. American Roentgen Ray Society 108th Annual Meeting. Washington, DC, US.
      85. 2008. Ovarian cancer screening: corpus luteum and other actors - how to sort them out. Conference. American Roentgen Ray Society 108th Annual Meeting. Washington, DC, US.
      86. 2008. Imaging findings after Whipple surgery. Conference. American Roentgen Ray Society 108th Annual Meeting. Washington, DC, US.
      87. 2008. The value of CT scan of abdomen and pelvis in patients with treated colorectal cancer in the setting of an undetectable CEA. Conference. Society of Gastrointestinal Radiology Annual Meeting. Rancho Mirage, CA, US.
      88. 2008. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Conference. Annual Meeting of the Society of Uroradiology. Rancho Mirage, CA, US.
      89. 2007. Pancreas-peritoneal reflections, ligamentous connections, and pathways of disease spread (selected for RadioGraphics). Conference. 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      90. 2007. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease (Cum Laude Award). Conference. 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      91. 2007. Sensitivity of PET positive adrenal nodules in a cancer population to determine malignancy. Conference. American Roentgen Ray Society 107th Annual Meeting. Orlando, FL, US.
      92. 2004. MR imaging of small bowel using orally-ingested hyperosmolar bowel distending agents (HOBDAs): correlation of pathological findings with conventional imaging techniques. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      93. 2003. MRI measurement of renal cortical perfusion and kidney volumes and MRA in patients with renovascular disease (RVD). Conference. 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
      94. 2003. Evaluation of renal GFR, with correction for body mass index, using perfusion and volume data from a 3D VIBE sequence used in magnetic resonance angiography. Conference. 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.

      International Presentations

      1. 2025. Imaging of urothelial carcinoma. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      2. 2025. Role in imaging of PET-CT of gynecologic malignancies and pitfalls of PET-CT. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      3. 2025. Characterization of adrenal mass. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      4. 2025. MRI in staging of penile and urethral carcinoma. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      5. 2025. Role of imaging in management of renal cell carcinoma. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      6. 2025. Imaging in staging of gynecologic malignancies. Invited. 2025 Joint Annual Convention Multimodal Mastery: Advancing Genitourinary Imaging with Ultrasound, CT and MRI. Manila, PH.
      7. 2017. Role of mpMRI prostate, optimal MRI protocol and P1-RADS v2. Invited. The 15th Urological Association of Asia Congress. Hong Kong, CN.
      8. 2017. MRI as a work up for prostate cancer. Invited. The 15th Urological Association of Asia Congress. Hong Kong, CN.
      9. 2016. Prostate cancer multiparametric MRI for prostate cancer. Invited. Malaysian Society of Urology. Kaula Lumpur, MY.
      10. 2016. Bladder cancer / kidney cancer MR/CT for renal masses. Invited. Malaysian Society of Urology. Kaula Lumpur, MY.
      11. 2016. State of the art lecture imaging in patients with chronic renal failure: what's new?. Invited. Malaysian Society of Urology. Kaula Lumpur, MY.
      12. 2016. Imaging in patients with chronic renal failure - controversies in contrast. Invited. UroRadiology Update - Hospital Serdang. Kaula Lumpur, MY.
      13. 2016. Multiparametric MRI of the prostate. Invited. UroRadiology Update - Hospital Serdang. Kaula Lumpur, MY.
      14. 2016. MRI of penis and urethra. Invited. UroRadiology Update - Hospital Serdang. Kaula Lumpur, MY.
      15. 2015. Feasibility study of contrast enhanced intraoperative ultrasound for detection and characterization of renal mass undergoing open partial nephrectomy. Conference. American Roentgen Ray Society 115th Annual Meeting. Toronto, CA.
      16. 2015. Utility of PET CT in prediction of response to neo-adjuvant therapy in patients with gastric carcinoma. Conference. European Congress of Radiology. Vienna, AT.
      17. 2013. PET CT in gynecological malignancies - evidence, findings and pitfalls. Invited. 20th Symposium of the European Society of Urogenital Radiology. Istanbul, TR.
      18. 2013. Characterization and staging of renal masses. Invited. 17th Annual Convention of the American College of Radiology and MD Anderson Cancer Center Categorical Course in Oncologic Imaging. San Juan, PR.
      19. 2013. Pre and post treatment imaging of RCC: can imaging predict histology?. Invited. American Society of Clinical Oncology, Society of Urologic Oncology, American Society for Radiation Oncology. Orlando, US.
      20. 2011. The CT urogram: technique, applications and findings. Invited. Oncologic Imaging: A Multidisciplinary Approach. Shanghai, CN.
      21. 2011. Imaging of bladder cancer. Invited. Oncologic Imaging: A Multidisciplinary Approach. Shanghai, CN.
      22. 2011. Panel Discussion: Genitourinary imaging. Invited. Oncologic Imaging: A Multidisciplinary Approach. Shanghai, CN.
      23. 2011. Colour Doppler ultrasound for calf vein deep venous thrombosis: what radiologists need to know. Conference. European Congress of Radiology. Vienna, AT.
      24. 2010. Radiofrequency ablation (RFA) of renal tumors: clinical, radiographic, and pathologic results from a tertiary cancer center (selected as highlights poster). Conference. 28th World Congress of Endourology & SWL. Chicago, US.
      25. 2010. Radiofrequency ablation (RFA) of renal tumors: clinical, radiographic, and pathologic results from a tertiary cancer center. Conference. Genitourinary Cancers Symposium. San Francisco, US.
      26. 2005. MRI of the small bowel: how we do it. Conference. United Kingdom Radiological Congress Annual Meeting. Birmingham, GB.
      27. 2005. Kidney length and volume measurements and glomerular filtration rate - improved identification of functional renovascular compensatory mechanisms using magnetic resonance volume imaging. Conference. 42nd Annual Meeting of the European Renal Association/European Dialysis and Transplant Association. Istanbul, TR.
      28. 2005. An anatomical study of retro-renal peritoneal extension and implications for safe percutaneous renal intervention. Conference. European Congress of Radiology. Vienna, AT.
      29. 2004. Retro renal peritoneal recess: an anatomical study. Conference. British Medical Ultrasound Society Annual Meeting. Manchester, GB.
      30. 2004. Cutting balloon angioplasty of vascular grafts: preliminary results. Invited. British Society of Interventional Radiologists Annual Meeting. Harrogate, GB.
      31. 2004. Trends in renal radiology departments with introduction of MR renal angiography. Invited. British Society of Interventional Radiologists Annual Meeting. Harrogate, GB.
      32. 2004. Kohler's "disease of the tarsal navicular bone" - a study to determine incidence and clinicoradiological correlation. Conference. European Pediatric Radiological Society 27th Postgraduate Course and 41st Annual Congress. Heidelberg, DE.
      33. 2004. Evaluation of split renal functions using data available from magnetic resonance renal angiography. Conference. 8th Annual Renovascular Forum. Birmingham, GB.
      34. 2002. Justifications of X-ray requests: how compliant are we with IRMER 2000?. Conference. Annual Scientific Meeting, Royal College of Radiology. London, GB.

      Formal Peers

      1. 2020. MRI in rectal carcinoma. Why? What? When? and How?. Visiting. Houston, TX, US.
      2. 2018. Master class on upper abdominal imaging-case conference and spread of disease within abdomen. Visiting. Dundee.
      3. 2018. MR and CT imaging characteristics of liver lesions at the Tayside Radiology Society. Visiting. Dundee.
      4. 2018. Registrars tutorial and case viewing. Visiting. Dundee.
      5. 2018. Pitfalls of PET CT. Invited. Pittsburgh, PA, US.
      6. 2017. Hand-on workshop on Pro-Fuse software. Visiting. Hong Kong, CN.
      7. 2017. Features of mpMRI and interpretation of PI-RADS v.2. Visiting. Hong Kong, CN.
      8. 2016. Bladder cancer / kidney cancer MR/CT for renal masses. Visiting. Kaula Lumpur, MY.
      9. 2016. State of the art lecture imaging in patients with chronic renal failure: what's new?. Visiting. Kaula Lumpur, MY.
      10. 2016. Prostate cancer multiparametric MRI for prostate cancer. Visiting. Kaula Lumpur, MY.
      11. 2016. Imaging in patients with chronic renal failure - controversies in contrast. Visiting. Kaula Lumpur, MY.
      12. 2016. Multiparametric MRI of the prostate. Visiting. Kaula Lumpur, MY.
      13. 2016. MRI of penis and urethra. Visiting. Kaula Lumpur, MY.
      14. 2014. Can cytopathology, radiology and molecular markers put together the pieces of the adrenal mass puzzle?. Visiting. Dallas, TX, US.
      15. 2013. Pre and post treatment imaging of RCC: can imaging predict histology?. Visiting. Orlando, FL, US.
      16. 2012. Oncologic imaging. Visiting. Perth, GB.
      17. 2011. TCC-CT urogram and MR urogram. Visiting. Houston, TX, US.
      18. 2011. The role of PET in gastric cancer. Visiting. San Antonio, TX, US.
      19. 2011. Staging of rectal cancer. Visiting. Houston, TX, US.
      20. 2009. Imaging in staging of pancreatic cancer. Invited. Bangalore, IN.
      21. 2009. Role of imaging in management - pancreatic cancer. Invited. Bangalore, IN.
      22. 2008. Peritoneal reflections and pathways of disease spread. Visiting. Dundee.
      23. 2008. Pancreatic adenocarcinoma and pathways of disease spread. Visiting. Dundee.
      24. 2008. Case review. Visiting. Dundee.
      25. 2008. Workflow management. reflections on two different health care systems. Invited. Dundee.
      Read More
      Less

      Grant & Contract Support

      Date: 2011 - 2012
      Title:High-frequency endoluminal ultrasonography for staging of upper tract urothelial carcinoma
      Funding Source:American Institute of Ultrasound in Medicine
      Role:Investigator

      Selected Publications

      Peer-Reviewed Articles

      1. Zhang M, Vikram R, Sung J, Wei P, Sircar K, Troncoso P, Pettaway C, Tamboli P, Czerniak B. De Novo and Postradiation Adenocarcinoma of the Urethra: A Clinicopathologic and Radiologic Study of 55 Cases. Am J Surg Pathol, 2026. e-Pub 2026. PMID: 42676055.
      2. Fallon EA, Awiwi MO, Bhutiani N, Helmink B, Scally CP, Mansfield P, Fournier K, Vikram R, Uppal A, White MG. ASO visual abstract: Peritoneal cancer index correlates with radiographic assessment of colorectal carcinomatosis. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 39847285.
      3. Fallon EA, Awiwi MO, Bhutiani N, Helmink B, Scally CP, Mansfield P, Fournier K, Vikram R, Uppal A, White MG. Peritoneal cancer index correlates with radiographic assessment of colorectal carcinomatosis. Ann Surg Oncol, 2024. e-Pub 2024. PMID: 39730964.
      4. Agnes A, Peacock O, Manisundaram N, Kim Y, Stanietzky N, Vikram R, Bednarski BK, Konishi T, You YN, Chang GJ. The learning curve for robotic lateral pelvic lymph node dissection for rectal cancer: A view from the west. Dis Colon Rectum 67(10):1281-1290, 2024. e-Pub 2024. PMID: 38959454.
      5. Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Albersen M, Roussel E, Master VA, Nazha B, Hernandez C, Moses KA, Protzel C, Montgomery J, Angel M, Tobias-Machado M, Spiess PE, Pettaway CA, Chahoud J. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: An international, multi-institutional, real-world study. J Natl Cancer Inst 116(6):966-973, 2024. e-Pub 2024. PMID: 38366627.
      6. Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Randomized phase 2 trial of Tremelimumab and Durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer 130(7):1061-1071, 2024. e-Pub 2024. PMID: 38009662.
      7. Awiwi MO, Gjoni M, Vikram R, Altinmakas E, Dogan H, Bathala TK, Naik S, Ravizzini G, Kandemirli SG, Elsayes KM, Salem UI. MRI and PSMA PET/CT of biochemical recurrence of prostate cancer. Radiographics 43(12):e230112, 2023. e-Pub 2023. PMID: 37999983.
      8. Stanietzky N, Bednarski B, Shafer A, Taggart MW, Peacock O, Vikram R. Rectal adenocarcinoma presenting as a cervical mass: A case report. Am J Case Rep 24:e941884, 2023. e-Pub 2023. PMID: 38011075.
      9. Peacock O, Manisundaram N, Kim Y, Konishi T, Stanietzky N, Vikram R, Bednarski BK, Nancy You Y, Chang GJ. Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything. Br J Surg 110(8):985-986, 2023. e-Pub 2023. PMID: 37150892.
      10. Awiwi MO, Abudayyeh A, Abdel-Wahab N, Diab A, Gjoni M, Xu G, Vikram R, Elsayes K. Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: A retrospective series of biopsy-proven cases. Eur Radiol 33(3):2227-2238, 2023. e-Pub 2023. PMID: 36255488.
      11. Peacock O, Manisundaram N, Dibrito SR, Kim Y, Hu CY, Bednarski BK, Konishi T, Stanietzky N, Vikram R, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Magnetic resonance imaging directed surgical decision making for lateral pelvic lymph node dissection in rectal cancer after total neoadjuvant therapy (TNT). Ann Surg 276(4):654-664, 2022. e-Pub 2022. PMID: 35837891.
      12. Ibarra Rovira J, Thirumurthi S, Taggart M, Yilmaz B, Lin H, Zhong LL, Ejezie CL, Akhmedzhanov FO, Zarifa A, Leung CH, Hong DS, Vikram R. Role of abdominal and pelvic CT scans in diagnosis of patients with immunotherapy-induced colitis. J Immunother Precis Oncol 5(2):32-36, 2022. e-Pub 2022. PMID: 35664090.
      13. Awiwi MO, Vikram R. Radiologic diagnosis and staging of bladder cancer: An update. J Comput Assist Tomogr 46(4):530-544, 2022. e-Pub 2022. PMID: 35723651.
      14. Doshi AM, Tong A, Davenport MS, Khalaf AM, Mresh R, Rusinek H, Schieda N, Shinagare AB, Smith AD, Thornhill R, Vikram R, Chandarana H. Assessment of renal cell carcinoma by texture analysis in clinical practice: a six-site, six-platform analysis of reliability. AJR Am J Roentgenol 217(5):1132-1140, 2021. e-Pub 2021. PMID: 33852355.
      15. Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA, Takahashi N. MR characteristics of mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: comparison with clear cell and papillary subtypes of renal cell carcinoma. Abdom Radiol (NY) 46(11):5250-5259, 2021. e-Pub 2021. PMID: 34338814.
      16. Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics analysis for predicting Pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer 9(4), 2021. e-Pub 2021. PMID: 33849924.
      17. Shinagare AB, Davenport MS, Park H, Pedrosa I, Remer EM, Chandarana H, Doshi AM, Schieda N, Smith AD, Vikram R, Wang ZJ, Silverman SG. Lexicon for renal mass terms at CT and MRI: a consensus of the Society of Abdominal Radiology disease-focused panel on renal cell carcinoma. Abdom Radiol (NY) 46(2):703-722, 2021. e-Pub 2021. PMID: 32809055.
      18. Bhutani MS, Vikram R, Mansfield PF. Should I admire the cecum for a while once I get there? A sequel. Gastrointest Endosc 93(1):268-269, 2021. e-Pub 2021. PMID: 32730822.
      19. Katabathina VS, Rajebi H, Chen M, Restrepo CS, Salman U, Vikram R, Menias CO, Prasad SR. Genetics and imaging of pheochromocytomas and paragangliomas: current update. Abdom Radiol (NY) 45(4):928-944, 2020. e-Pub 2020. PMID: 31069476.
      20. Pan T, Hasegawa A, Luo D, Wu CC, Vikram R. Technical note: impact on central frequency and noise magnitude ratios by advanced CT image reconstruction techniques. Med Phys 47(2):480-487, 2020. e-Pub 2020. PMID: 31778233.
      21. Davenport MS, Hu EM, Zhang A, Shinagare AB, Smith AD, Pedrosa I, Kaffenberger SD, Silverman SG, SAR Disease-Focused Panel on RCC. Standardized report template for indeterminate renal masses at CT and MRI: a collaborative product of the SAR disease-focused panel on renal cell carcinoma. Abdom Radiol (NY) 44(4):1423-1429, 2019. e-Pub 2019. PMID: 30511089.
      22. Ganeshan D, Amini B, Nikolaidis P, Assing M, Vikram R. Current update on desmoid fibromatosis. J Comput Assist Tomogr 43(1):29-38, 2019. e-Pub 2019. PMID: 30211798.
      23. Fernández MI, Brausi M, Clark PE, Cookson MS, Grossman HB, Khochikar M, Kiemeney LA, Malavaud B, Sanchez-Salas R, Soloway MS, Svatek RS, Vikram R, Vrieling A, Kamat AM. Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer. World J Urol 37(1):3-13, 2019. e-Pub 2019. PMID: 30105454.
      24. Farnum JA, Vikram R, Rao A, Bedi D, Dinney CP, Matin SF. Accuracy of high-frequency endoluminal ultrasonography for clinical staging of upper tract urothelial carcinoma. J Endourol 32(9):806-811, 2018. e-Pub 2018. PMID: 30014707.
      25. Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the urethra. Hum Pathol 72:35-44, 2018. e-Pub 2018. PMID: 28827100.
      26. Le O, Wood C, Vikram R, Patnana M, Bhosale P, Bassett R, Bedi D. Feasibility of contrast-enhanced intraoperative ultrasound for detection and characterization of renal mass undergoing open partial nephrectomy. J Ultrasound Med 36(8):1547-1553, 2017. e-Pub 2017. PMID: 28390143.
      27. Huo J, Chu Y, Chamie K, Smaldone MC, Boorjian SA, Baillargeon JG, Kuo YF, Kerr P, O'Malley P, Orihuela E, Tyler DS, Freedland SJ, Giordano SH, Vikram R, Kamat AM, Williams SB. Increased utilization of positron emission tomography/computed tomography (PET/CT) imaging and its economic impact for patients diagnosed with bladder cancer. Clin Genitourin Cancer. e-Pub 2017. PMID: 28826932.
      28. Bilen MA, Cauley DH, Atkinson BJ, Chen HC, Kaya DH, Wang X, Vikram R, Tu SM, Corn PG, Kim J. Safety of same-day Pegfilgrastim administration in metastatic castration-resistant prostate cancer treated with Cabazitaxel with or without Carboplatin. Clin Genitourin Cancer 15(3):e429-e435, 2017. e-Pub 2017. PMID: 28038931.
      29. Katabathina VS, Vikram R, Olaoya A, Paspulati RM, Nicolas MM, Rao P, Zaheer A, Prasad SR. Neuroendocrine neoplasms of the genitourinary tract in adults: cross-sectional imaging spectrum. Abdom Radiol (NY) 42(5):1472-1484, 2017. e-Pub 2017. PMID: 27942847.
      30. Ejaz S, Vikram R, Stroehlein JR. Non-Meckel small intestine diverticulitis. Case Rep Gastroenterol 11(2):462-472, 2017. e-Pub 2017. PMID: 29033764.
      31. Davenport MS, Hu EM, Smith AD, Chandarana H, Hafez K, Palapattu GS, Stuart Wolf J, Silverman SG, Cell Carcinoma SOARDFPOR. Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists. Abdom Radiol (NY) 42(4):1229-1240, 2017. e-Pub 2017. PMID: 27878338.
      32. Zhang M, Pettaway C, Vikram R, Tamboli P. Adenoid cystic carcinoma of the urethra/cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol 58:138-144, 2016. e-Pub 2016. PMID: 27554206.
      33. Huang H, Tamboli P, Karam JA, Vikram R, Zhang M. Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases. Hum Pathol 52:55-60, 2016. e-Pub 2016. PMID: 26980018.
      34. Vikram R, Beland MD, Blaufox MD, Moreno CC, Gore JL, Harvin HJ, Heilbrun ME, Liauw SL, Nguyen PL, Nikolaidis P, Preminger GM, Purysko AS, Raman SS, Taffel MT, Wang ZJ, Weinfeld RM, Remer EM, Lockhart ME. ACR appropriateness criteria® renal cell carcinoma staging. J Am Coll Radiol 13(5):518-25, 2016. e-Pub 2016. PMID: 27016804.
      35. Ghosh P, Tamboli P, Vikram R, Rao A. Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features. J Med Imaging (Bellingham) 2(4):041009, 2015. e-Pub 2015. PMID: 26839909.
      36. Shinagare AB, Vikram R, Jaffe C, Akin O, Kirby J, Huang E, Freymann J, Sainani NI, Sadow CA, Bathala TK, Rubin DL, Oto A, Heller MT, Surabhi VR, Katabathina V, Silverman SG. Radiogenomics of clear cell renal cell carcinoma: preliminary findings of the cancer genome atlas-renal cell carcinoma (TCGA-RCC) imaging research group. Abdom Imaging 40(6):1684-92, 2015. e-Pub 2015. PMID: 25753955.
      37. Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JA. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU Int 116(1):85-92, 2015. e-Pub 2015. PMID: 25395040.
      38. Heilbrun ME, Remer EM, Casalino DD, Beland MD, Bishoff JT, Blaufox MD, Coursey CA, Goldfarb S, Harvin HJ, Nikolaidis P, Preminger GM, Raman SS, Sahni A, Vikram R, Weinfeld RM. ACR appropriateness criteria® indeterminate renal mass. J Am Coll Radiol 12(4):333-41, 2015. e-Pub 2015. PMID: 25842014.
      39. Morani AC, Vicens RA, Wei W, Gupta S, Vikram R, Balachandran A, Reed BJ, Ma J, Qayyum A, Szklaruk J. CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRI at 1.5 T: a comparative in vivo patient study. J Comput Assist Tomogr 39(2):263-9, 2015. e-Pub 2015. PMID: 25635931.
      40. Karam JA, Wood CG, Compton ZR, Rao P, Vikram R, Ahrar K, Matin SF. Salvage surgery after energy ablation for renal masses. BJU Int 115(1):74-80, 2015. e-Pub 2015. PMID: 24656119.
      41. Dayyani F, Hoffman K, Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Management of advanced primary urethral carcinomas. BJU Int 114(1):25-31, 2014. e-Pub 2014. PMID: 24447439.
      42. Viswanathan C, Truong MT, Sagebiel TL, Bronstein Y, Vikram R, Patnana M, Silverman PM, Bhosale PR. Abdominal and pelvic complications of nonoperative oncologic therapy. Radiographics 34(4):941-61, 2014. e-Pub 2014. PMID: 25019433.
      43. Casalino DD, Remer EM, Bishoff JT, Coursey CA, Dighe M, Harvin HJ, Heilbrun ME, Majd M, Nikolaidis P, Preminger GM, Raman SS, Sheth S, Vikram R, Weinfeld RM. ACR appropriateness criteria® post-treatment follow-up of renal cell carcinoma. J Am Coll Radiol 11(5):443-9, 2014. e-Pub 2014. PMID: 24793039.
      44. Vicens RA, Balachandran A, Guo CC, Vikram R. Multimodality imaging of thyroid-like follicular renal cell carcinoma with lung metastases, a new emerging tumor entity. Abdom Imaging 39(2):388-93, 2014. e-Pub 2014. PMID: 24343809.
      45. Tirumani SH, Shanbhogue AK, Vikram R, Prasad SR, Menias CO. Imaging of the porta hepatis: spectrum of disease. Radiographics 34(1):73-92, 2014. e-Pub 2014. PMID: 24428283.
      46. Viswanathan C, Bhosale PR, Shah SN, Vikram R. Positron emission tomography-computed tomography imaging for malignancies in women. Radiol Clin North Am 51(6):1111-25, 2013. e-Pub 2013. PMID: 24210447.
      47. Karam JA, Ahrar K, Vikram R, Romero CA, Jonasch E, Tannir NM, Rao P, Wood CG, Matin SF. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int 111(6):997-1005, 2013. e-Pub 2013. PMID: 23510233.
      48. Balachandran A, Tamm EP, Bhosale PR, Patnana M, Vikram R, Fleming JB, Katz MH, Charnsangavej C. Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 38(2):342-57, 2013. e-Pub 2013. PMID: 22707246.
      49. Maturen KE, Vikram R, Wu AJ, Francis IR. Renal vein leiomyosarcoma: imaging and clinical features of a renal cell carcinoma mimic. Abdom Imaging 38(2):379-87, 2013. e-Pub 2013. PMID: 22476373.
      50. Tamm EP, Bhosale PR, Vikram R, de Almeida Marcal LP, Balachandran A. Imaging of pancreatic ductal adenocarcinoma: State of the art. World J Radiol 5(3):98-105, 2013. e-Pub 2013. PMID: 23671746.
      51. Bhosale P, Balachandran A, Vikram R, Viswanathan C, Macapinlac H, Rohren E, Prativadi R. What is the clinical significance of FDG unexpected uptake in the prostate in patients undergoing PET/CT for other malignancies?. Int J Mol Imaging 2013:476786, 2013. e-Pub 2013. PMID: 24455242.
      52. Shanbhogue AK, Vikram R, Paspulati RM, MacLennan G, Verma S, Sandrasegaran K, Prasad SR. Rare (<1%) histological subtypes of renal cell carcinoma: an update. Abdom Imaging 37(5):861-872, 2012. e-Pub 2012. PMID: 22075767.
      53. Philips S, Shah SN, Vikram R, Verma S, Shanbhogue AK, Prasad SR. Pancreatic endocrine neoplasms: a current update on genetics and imaging. Br J Radiol 85(1014):682-96, 2012. e-Pub 2012. PMID: 22253347.
      54. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M, Screening Consortium ACOTP. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804; quiz e14-5, 2012. e-Pub 2012. PMID: 22245846.
      55. Lalwani N, Shanbhogue AK, Bhargava P, Vikram R, Prasad SR. Rare, miscellaneous primary ovarian neoplasms: spectrum of cross-sectional imaging. Curr Probl Diagn Radiol 41(2):73-80, 2012. e-Pub 2012. PMID: 22285004.
      56. Philips S, Menias C, Vikram R, Sunnapwar A, Prasad SR. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr 36(2):207-12, 2012. e-Pub 2012. PMID: 22446361.
      57. Philips S, Nagar A, Dighe M, Vikram R, Sunnapwar A, Prasad S. Benign non-cystic scrotal tumors and pseudotumors. Acta Radiol 53(1):102-111, 2012. e-Pub 2012. PMID: 22025740.
      58. Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Eggli DF, Fulgham P, Israel GM, Lazarus E, Leyendecker JR, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. ACR appropriateness criteria® post-treatment follow-up of prostate cancer. J Am Coll Radiol 8(12):863-871, 2011. e-Pub 2011. PMID: 22137005.
      59. Tan CH, Vikram R, Boonsirikamchai P, Bhosale P, Marcal L, Faria S, Charnsangavej C. Extramural venous invasion by gastrointestinal malignancies: CT appearances. Abdom Imaging 36(5):491-502, 2011. e-Pub 2011. PMID: 21184063.
      60. Shanbhogue AK, Virmani V, Vikram R, Prasad SR, Shanbhogue DK, Nagar A, Fasih N. Spectrum of medication-induced complications in the abdomen: role of cross-sectional imaging. AJR Am J Roentgenol 197(2):W286-W294, 2011. e-Pub 2011. PMID: 21785055.
      61. Tan CH, Wang M, Fu WJ, Vikram R. Nodular extramedullary multiple myeloma: hepatic involvement presenting as hypervascular lesions on CT. Ann Acad Med Singapore 40(7):329-331, 2011. e-Pub 2011. PMID: 21870026.
      62. Vikram R, Balachandran A. Imaging in staging and management of pancreatic ductal adenocarcinoma. Indian J Surg Oncol 2(2):78-87, 2011. e-Pub 2011. PMID: 22693399.
      63. Lalwani N, Prasad SR, Vikram R, Katabathina V, Shanbhogue A, Restrepo C. Pediatric and adult primary sarcomas of the kidney: a cross-sectional imaging review. Acta Radiol 52(4):448-457, 2011. e-Pub 2011. PMID: 21498303.
      64. Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31(3):625-646, 2011. e-Pub 2011. PMID: 21571648.
      65. Tan CH, Tamm EP, Marcal L, Balachandran A, Charnsangavej C, Vikram R, Bhosale P. Imaging features of hematogenous metastases to the pancreas: pictorial essay. Cancer Imaging 11:9-15, 2011. e-Pub 2011. PMID: 21367687.
      66. Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Zaheer A, Sandrasegaran K. Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics 31(2):393-408, 2011. e-Pub 2011. PMID: 21415186.
      67. Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr 35(2):159-166, 2011. e-Pub 2011. PMID: 21412084.
      68. Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. Radiology 258(3):673-693, 2011. e-Pub 2011. PMID: 21339346.
      69. Tan CH, Vikram R, Boonsirikamchai P, Faria SC, Charnsangavej C, Bhosale PR. Pathways of extrapelvic spread of pelvic disease: imaging findings. Radiographics 31(1):117-133, 2011. e-Pub 2011. PMID: 21257938.
      70. Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Radiofrequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol 184(5):1882-1887, 2010. e-Pub 2010. PMID: 20846689.
      71. Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SR. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics 30(6):1525-1540, 2010. e-Pub 2010. PMID: 21071373.
      72. Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol 194(5):W401-W406, 2010. e-Pub 2010. PMID: 20410385.
      73. Lalwani N, Shanbhogue AK, Vikram R, Nagar A, Jagirdar J, Prasad SR. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol 194(2):330-336, 2010. e-Pub 2010. PMID: 20093592.
      74. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol 192(6):1488-1493, 2009. e-Pub 2009. PMID: 19457809.
      75. Rampurwala M, Ravoori MK, Wei W, Johnson VE, Vikram R, Kundra V. Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer. Transl Oncol 2(2):96-106, 2009. e-Pub 2009. PMID: 19412425.
      76. Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741-754; discussion 755-757, 2009. e-Pub 2009. PMID: 19448113.
      77. Vikram R, Balachandran A, Bhosale PR, Tamm EP, Marcal LP, Charnsangavej C. Pancreas: peritoneal reflections, ligamentous connections, and pathways of disease spread. Radiographics 29(2):e34, 2009. e-Pub 2009. PMID: 19168761.
      78. Vikram R, Yeung HD, Macapinlac HA, Iyer RB. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. AJR Am J Roentgenol 191(5):1545-1551, 2008. e-Pub 2008. PMID: 18941099.
      79. Vikram R, Yang T, Kundra V. The value of CT scan of abdomen and pelvis in patients with treated colorectal cancer in the setting of an undetectable carcinoembryonic antigen (CEA). AJR Am J Roentenol 190(4 Suppl), 2008. e-Pub 2008.
      80. Bhat R, McBride K, Chakraverty S, Vikram R, Severn A. Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: long-term results from three centers. Cardiovasc Intervent Radiol 30(6):1166-1170, 2007. e-Pub 2007. PMID: 17710477.
      81. Vikram R, Ross RA, Bhat R, Griffiths GD, Stonebridge PA, Houston JG, Chakraverty S. Cutting balloon angioplasty versus standard balloon angioplasty for failing infra-inguinal vein grafts: comparative study of short- and mid-term primary patency rates. Cardiovasc Intervent Radiol 30(4):607-610, 2007. e-Pub 2007. PMID: 17393055.
      82. Vikram R, Iyer RB, Yeung H, Macapinlac H. Sensitivity of PET-positive adrenal nodules in a cancer population to determine malignancy. AJR Am J Roentgenol 188(5 Suppl), 2007. e-Pub 2007.
      83. Vikram R, McCulloch AS, Zealley IA. True gastrogastric intussusception: a rare radiologic diagnosis with surgical correlation. AJR Am J Roentgenol 186(2):585-586, 2006. e-Pub 2006. PMID: 16423980.
      84. Al Mahri AS, Gandy SJ, Armoogum K, Vikram R, Houston JG. Kidney length and volume measurements and glomerular filtration rate - improved identification of functional renovascular compensatory mechanisms using magnetic resonance volume imaging. Nephrol Dial Transplant 20(5 Suppl):V280, 2005. e-Pub 2005.

      Review Articles

      1. Stanietzky N, Morani A, Surabhi V, Jensen C, Horvat N, Vikram R. Mucinous rectal adenocarcinoma-challenges in magnetic resonance imaging interpretation. J Comput Assist Tomogr 48(5):683-692, 2024. e-Pub 2024. PMID: 38446711.
      2. Alhalabi O, Groisberg R, Zinner R, Hahn AW, Naing A, Zhang S, Tsimberidou AM, Rodon J, Fu S, Yap TA, Hong DS, Sun M, Jiang Y, Pant S, Shah AY, Zurita A, Tannir NM, Vikram R, Roszik J, Meric-Bernstam F, Subbiah V. Phase I study of Sapanisertib with Carboplatin and Paclitaxel in mTOR pathway altered solid malignancies. NPJ Precis Oncol 7(1):37, 2023. e-Pub 2023. PMID: 37072571.
      3. Hensley PJ, Panebianco V, Pietzak E, Kutikov A, Vikram R, Galsky MD, Shariat SF, Roupret M, Kamat AM. Contemporary staging for muscle-invasive bladder cancer: accuracy and limitations. Eur Urol Oncol 5(4):403-411, 2022. e-Pub 2022. PMID: 35581143.
      4. Virarkar M, Patnana M, Vikram R, Bhargava P, Birkenfeld E, Sagebiel T. Unravelling adrenal oncocytic neoplasm. Clin Genitourin Cancer 17(1):e216-e220, 2019. e-Pub 2019. PMID: 30454970.
      5. Amini B, Yellapragada S, Shah S, Rohren E, Vikram R. State-of-the-art imaging and staging of plasma cell dyscrasias. Radiol Clin North Am 54(3):581-96, 2016. e-Pub 2016. PMID: 27153790.
      6. Remer EM, Papanicolaou N, Casalino DD, Bishoff JT, Blaufox MD, Coursey CA, Dighe M, Eberhardt SC, Goldfarb S, Harvin HJ, Heilbrun ME, Leyendecker JR, Nikolaidis P, Oto A, Preminger GM, Raman SS, Sheth S, Vikram R, Weinfeld RM. ACR appropriateness criteria® on renal failure. Am J Med 127(11):1041-8.e1, 2014. e-Pub 2014. PMID: 24865874.
      7. Katabathina VS, Garg D, Prasad SR, Vikram R. Cystic renal neoplasms and renal neoplasms associated with cystic renal diseases in adults: cross-sectional imaging findings. J Comput Assist Tomogr 36(6):659-668, 2012. e-Pub 2012. PMID: 23192202.
      8. Coursey CA, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Dighe M, Fulgham P, Goldfarb S, Israel GM, Lazarus E, Leyendecker JR, Majd M, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. ACR appropriateness criteria® acute onset flank pain--suspicion of stone disease. Ultrasound Q 28(3):227-33, 2012. e-Pub 2012. PMID: 22902840.
      9. Remer EM, Casalino DD, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Fulgham P, Israel GM, Lazarus E, Leyendecker JR, Majd M, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R, Karmazyn B. ACR appropriateness criteria® acute onset of scrotal pain-without trauma, without antecedent mass. Ultrasound Q 28(1):47-51, 2012. e-Pub 2012. PMID: 22357246.
      10. Heng Tan C, Bedi D, Vikram R. Sonography of thrombosis of the deep veins of the extremities: clinical perspectives and imaging review. J Clin Ultrasound 40(1):31-43, 2012. e-Pub 2012. PMID: 22105376.
      11. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol 192(6):1481-7, 2009. e-Pub 2009. PMID: 19457808.
      12. Vikram R, Iyer RB. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 8 Spec No A:S46-51, 2008. e-Pub 2008. PMID: 18852081.

      Professional Educational Materials

      1. Oto A, Yacoub JH, Casalino DD, Remer EM, Blaufox D, Bishoff JT, Coursey CA, Dighe M, Eberhardt SC, Harvin HJ, Lazarus E, Leyendecker JR, Lockhart ME, Nikolaidis P, Porter C, Ramchandani P, Sheth S, Vikram R. Staging of testicular malignancy. American College of Radiology Appropriateness Criteria®, 2012.
      2. Casalino DD, Remer EM, Bishoff JT, Coursey CA, Dighe M, Eberhardt SE, Goldfarb S, Harvin HJ, Lazarus E, Leyendecker JR, Lockhart ME, Majd M, Oto A, Porter C, Ramchandani P, Sheth S, Vikram R. Acute pyelonephritis. American College of Radiology Appropriateness Criteria®, 2012.
      3. Remer EM, Casalino DD, Bishoff JT, Coursey CA, Dighe M, Eberhardt SE, Goldfarb S, Harvin HJ, Lazarus E, Leyendecker JR, Lockhart ME, Majd M, Nikolaidis P, Oto A, Porter C, Ramchandani P, Sheth S, R V. Incidentally discovered adrenal mass. American College of Radiology Appropriateness Criteria®, 2012.
      4. Harvin HJ, Casalino DD, Remer EM, Bishoff JT, Coursey CA, Dighe M, Eberhardt SC, Goldfarb S, Lazarus E, Leyendecker JR, Lockhart ME, Majd M, Nikolaidis P, Oto A, Porter C, Ramchandani P, Sheth S, Vikram R. Renovascular hypertension. American College of Radiology Appropriateness Criteria®, 2012.
      5. Dighe M, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Fulgham P, Goldfarb S, Israel GM, Lazarus E, Leyendecker JR, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. Obstructive voiding symptoms secondary to prostate disease. American College of Radiology Appropriateness Criteria®, 2011.
      6. Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Eggli DF, Fulgham P, Israel GM, Lazarus E, Leyendecker JR, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. Post-treatment follow-up of prostate cancer. American College of Radiology Appropriateness Criteria®, 2011.
      7. Vikram R, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Eggli DF, Fulgham P, Israel GM, Lazarus E, Leyendecker JR, Nikolaidis P, Papanicolaou N, Ramchandani P, Sheth S. Renal cell carcinoma staging. American College of Radiology Appropriateness Criteria®, 2011.
      8. Lazarus E, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Eggli DF, Fulgham P, Goldfarb S, Israel GM, Leyendecker JR, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. Recurrent lower urinary tract infections in women. American College of Radiology Appropriateness Criteria®, 2011.
      9. Coursey CA, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Dighe M, Fulgham P, Goldfarb S, Israel GM, Lazarus E, Leyendecker JR, Majd M, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. Acute onset flank pain - suspicion of stone disease. American College of Radiology Appropriateness Criteria®, 2011.
      10. Remer EM, Casalino DD, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Fulgham P, Israel GM, Lazarus E, Leyendecker JR, Majd M, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R, Karmazyn B. Acute onset of scrotal pain - without trauma, without antecedent mass. American College of Radiology Appropriateness Criteria®, 2011.
      11. Israel GM, Casalino DD, Remer EM, Arellano RS, Bishoff JT, Coursey CA, Dighe M, Eggli DF, Fulgham P, Goldfarb S, Lazarus E, Leyendecker JR, Nikolaidis P, Papanicolaou N, Prasad S, Ramchandani P, Sheth S, Vikram R. Indeterminate renal masses. American College of Radiology Appropriateness Criteria®, 2011.
      12. Kedzierska K, Vikram R. Case in point: Cowden Disease. American College of Radiology, 2010.

      Abstracts

      1. Rajebi H, Olmsted RE, Rikhtehgar OY, Restrepo CS, Vikram R, Menias CO, Prasad SR, Katabathina VS. A tale of two tumors: current update in genetics and imaging of pheochromocytomas and paragangliomas. 103rd Radiological Society of North America Proceedings, 2017. e-Pub 2017.
      2. Remer EM, Raman SS, Vikram R. Renal cell carcinoma: how imaging can be used to select amount treatment options and monitor response. 103rd Radiological Society of North America Proceedings, 2017. e-Pub 2017.
      3. Remer EM, Raman SS, Vikram R. Renal cell carcinoma: how imaging can be used to select among treatment options and monitor response. 102nd Radiological Society of North America Proceedings, 2016. e-Pub 2016.
      4. Kaya D, Ganeshan B, Amini B, Tamboli P, Wood CG, Vikram R. Genitourinary (evaluation of renal masses): differentiation of papillary type 1 and type 2 RCC on CT textural analysis. 102nd Radiological Society of North America Proceedings, 2016. e-Pub 2016.
      5. Morani A, Kaur H, Vikram R, Bednarski B, Messick C, Rodriguez-Bigas M, Ernst R. Challenges and solution of inter observer variability in the interpretation of high resolution MRI in staging of primary rectal cancer. 101st Radiological Society of North America Proceedings, 2015. e-Pub 2015.
      6. Remer E, Raman S, Vikram R. Renal cell carcinoma: how imaging can be used to select among treatment options and monitor response. 101st Radiological Society of North America Proceedings, 2015. e-Pub 2015.
      7. Morani A, Kaur H, Vikram R, You Y, Taggart M, Chang G, Ernst R. Interobserver variability in interpretation of high resolution MRI of primary rectal cancer. 101st Radiological Society of North America Proceedings, 2015. e-Pub 2015.
      8. Rubin D, Flanders A, Burnside E, Vikram R, Filice R. Tapping into big data in images: annotation and image markup, tools, and applications (Hands-on). 100th Radiological Society of North America Proceedings, 2014. e-Pub 2014.
      9. Vikram R. Image texture analysis to predict BAP1 mutational status in patients with clear cell renal. Society of Abdominal Radiology Proceedings, 2014. e-Pub 2014.
      10. Vikram R, Ghosh P, Tamboli P, Rao A. Image texture analysis on primary tumor can stratify differences in overall survival, distant metastases, tumor stage, and Fuhrman grade in patients with clear cell renal carcinoma: results of a feasibility study. 99th Radiological Society of North America Proceedings, 2013. e-Pub 2013.
      11. Ghosh P, Rao A, Tamboli P, Vikram R. Image features derived from contrast enhanced CT can predict BAP1 loss in patients with clear cell renal carcinoma: results of a feasibility study. 99th Radiological Society of North America Proceedings, 2013. e-Pub 2013.
      12. Vikram R, Balachandran A, Wood C, Tamboli P, Garg N, Katabathina V, Prasad S. Cystic nephroma and mixed epithelial and stromal tumor of the kidney: a single clinical entity?. 99th Radiological Society of North America Proceedings, 2013. e-Pub 2013.
      13. Le O, Tamboli P, Wood C, Bedi D, Sandler C, Vikram R. MDCT in differentiating pT1-2 from pT3 tumors in renal cell carcinoma. Abdominal Radiology Course Syllabus:90, 2011. e-Pub 2011.
      14. Katabathina V, Paspulati R, Zaheer A, Vikram R, MacLennan GT, Shanbhogue A, Prasad SR. Neuroendocrine tumors of the genitourinary tract in adults: cross-sectional imaging findings. Abdominal Radiology Course Syllabus:93, 2011. e-Pub 2011.
      15. Bhosale PR, Prativadi RG, Balachandran A, Vikram R, Wei W, Devine CE, Kundra V, Rohren EM. What is the clinical significance of FDG uptake in the prostate in a patient undergoing a PET/CT?. 96th Radiological Society of North America Proceedings, 2010. e-Pub 2010.
      16. Tamm EP, Dunnington JS, Bhosale PR, Vikram R, Kaur H, Szklaruk J, Kundra V. Quality improvement in CT: a program for modifying/improving abdominal/pelvic CT imaging protocols while maintaining throughput in a large clinical practice. 96th Radiological Society of North America Proceedings, 2010. e-Pub 2010.
      17. Canto MI, Schulick RD, Kamel IR, Fishman EK, Topazian MD, Takahashi N, Lee JH, Tamm EP, Vikram R, Syngal S, Saltzman JR, Mortele KJ, Farrell JJ, Margolis D, Zhang Z, Petersen GM, Hruban RH, Goggins MG. Screening for familial pancreatic neoplasia: a prospective, multicenter blinded study of EUS, CT, and secretin-MRCP (The NCI-Spore Lustgarten Foundation Cancer of the Pancreas CAPS 3 Study). Digestive Disease Week Abstract Issue, Gastrointest Endosc 71(5):AB119, 2010. e-Pub 2010.
      18. Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Radiofrequency ablation (RFA) of renal tumors: clinical, radiographic, and pathologic results from a tertiary cancer center. Genitourinary Cancers Symposium Proceedings. e-Pub 2010.
      19. Dimigen M, Wilkinson G, Vikram R. Kohler’s disease of the tarsal navicular bone: does it exist?. 95th Radiological Society of North America Proceedings, 2009. e-Pub 2009.
      20. Tan CH, Vikram R, Boonsirikamchai P, Bhosale PR, Marcal LP, Charnsangavej C. Extramural venous invasion by gastrointestinal malignancies: CT appearances. 95th Radiological Society of North America Proceedings, 2009. e-Pub 2009.
      21. Vikram R, Ripley C, Zealley I. An anatomical study of retro-renal peritoneal extension and implications for safe percutaneous renal intervention. European Congress of Radiology Book of Abstracts, Eur Radiol 15(Suppl 1):329, 2005. e-Pub 2005.
      22. Vikram R, Allan L, Gandy S, Sheppard D, Davidson J, Houston G. Evaluation of split renal functions using data available from magnetic resonance renal angiography. Abstracts of the VIIIth Renovascular Forum, J Renovascular Dis 3:9-10. e-Pub 2004.
      23. Zealley IA, Vikram R, Kumar AB, Parasu N, Callaghan M. MR imaging of small bowel using orally-ingested hyperosmolar bowel distending agents (HOBDAs): correlation of pathological findings with conventional imaging techniques. 90th Radiological Society of North America Proceedings, 2004. e-Pub 2004.
      24. Vikram R, Wilkinson AJ. Kohler's "disease of the tarsal navicular bone" - a study to determine incidence and clinicoradiological correlation. European Pediatric Radiological Society 27th Postgraduate Course and 41st Annual Congress: Proceedings, Pediatr Radiol 34(Suppl 2):S105, 2004. e-Pub 2004.
      25. Vikram R, Ross R, Griffiths G, Stonebridge P, Houston G, Chakraverty S. Cutting balloon angioplasty of vascular grafts - preliminary results. The British Society of Interventional Radiologists Proceedings, 2004. e-Pub 2004.
      26. Vikram R, Gandy S, Macullay T, Forbes M, Houston G. Trends in renal radiology department with introduction of MR renal angiography. The British Society of Interventional Radiologists Proceedings, 2004. e-Pub 2004.
      27. Vikram R, Gandy S, Arumugam C, Sudarshan T, Sheppard D, Houston G. MRI measurement of renal cortical perfusion and kidney volumes and MRA in patients with renovascular disease (RVD). 89th Radiological Society of North America Proceedings, 2003. e-Pub 2003.
      28. Vikram R, Allan LC, Gandy SJ, Sheppard DG, Davidson J, Houston GJ. Evaluation of renal GFR with correction for body mass index, using perfusion and volume data from a 3D vibe sequence used in magnetic resonance angiography. 89th Radiological Society of North America Proceedings:390, 2003. e-Pub 2003.
      29. Vikram R, Alexander P, Main G, Cook A. Justifications of x-ray requests: how compliant are we with IRMER 2000?. Royal College of Radiologists Proceedings, 2002. e-Pub 2002.

      Book Chapters

      1. Vikram R, Ikoma N, Patnana M, Devine C, Mansfield P, Phan A. Gastric Carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach (Second Edition). Elsevier Saunders, 234 - 249, 2022.
      2. Vikram R, Jonasch E. Renal Tumors. In: Oncologic Imaging: A Multidisciplinary Approach (Second Edition). Elsevier Saunders, 285 - 308, 2022.
      3. Le O, Verma S, Rajesh A, Vikram R. Carcinoma of the Bladder and Urethra. In: Imaging of the Pelvis, Musculoskeletal System, and Special Applications to CAD. CRC Press Taylor & Francis Group, 556, 2016.
      4. Verma S, Gollamudi J, Vikram R, Rajesh A. Current Imaging Techniques for the Diagnosis Correlation With Pathology and Staging of Bladder Cancer. In: Advances in Surgical Pathology Bladder Cancer, 251-261, 2015.
      5. Vikram R, Patnana M, Devine C, Mansfield P, Phan A. Gastric Carcinoma. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Saunders, 231-246, 2012.
      6. Sandler C, Vikram R, Matin S, Wood C, Jonasch E. Renal Tumors. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier Saunders, 287-309, 2012.
      7. Vikram R, Bedi DG. Deep Vein Thrombosis in Critically Ill Patients: Ultrasound Diagnosis. In: Critical Care for Cancer Patients. Springer, 131-155, 2011.
      8. Patnana M, Vikram R. New Staging System for Gastric Cancer. In: Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams & Wilkins, 266-282, 2011.

      Letters to the Editor

      1. Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Author response to Cunha et al. J Immunother Cancer 9, 2021.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 10, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top